Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | 12-1986 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 42,167 | 31,646 | 21,693 | 16,780 | N/A |
| Depreciation Amortization | N/A | 20,207 | N/A | N/A | N/A |
| Other Working Capital | -36,192 | 18,766 | -26,510 | N/A | N/A |
| Other Operating Activity | 35,878 | -44,423 | 0 | 5,137 | 0 |
| Operating Cash Flow | $41,853 | $26,196 | $-4,817 | $21,917 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -34,028 | N/A | -28,075 | N/A | N/A |
| Net Acquisitions | -4,495 | N/A | -43,786 | 172 | N/A |
| Other Investing Activity | 771 | 0 | -6,276 | 10,881 | 0 |
| Investing Cash Flow | $-37,752 | $N/A | $-78,137 | $11,053 | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -8,931 | N/A | -6,531 | 18,185 | N/A |
| Other Financing Activity | 26,465 | 0 | 54,569 | -11,297 | 0 |
| Financing Cash Flow | $17,534 | $N/A | $48,038 | $6,888 | $N/A |
| Beginning Cash Position | 4,884 | N/A | 49,830 | 31,074 | N/A |
| End Cash Position | 26,519 | N/A | 14,914 | 43,811 | N/A |
| Net Cash Flow | $21,635 | $26,196 | $-34,916 | $39,858 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 41,853 | 26,196 | -4,817 | 21,917 | N/A |
| Free Cash Flow | 41,853 | 26,196 | -4,817 | 21,917 | 0 |